BI 691751

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BI 691751, covering 2014-07-24 to 2016-02-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Single Rising Doses and Relative Bioavailability of BI 691751 [Phase 1]